Cargando…

Upregulation of miR-34c after silencing E2F transcription factor 1 inhibits paclitaxel combined with cisplatin resistance in gastric cancer cells

BACKGROUND: MicroRNA 34c (miR-34c) has been reported to be associated with malignant types of cancer, however, it remains unknown whether miR-34c is involved in chemoresistance in gastric cancer (GC). AIM: To investigate the effect of miR-34c and its upstream transcription factor E2F1 on paclitaxel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Hong, Wang, Jin-Jing, Yang, Xiao-Rong, Yu, Yong-Lin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2020
Materias:	Case Control Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7015722/ https://www.ncbi.nlm.nih.gov/pubmed/32089626 http://dx.doi.org/10.3748/wjg.v26.i5.499

Ejemplares similares

Atrophic gastritis and gastric cancer tissue miRNome analysis reveals hsa-miR-129-1 and hsa-miR-196a as potential early diagnostic biomarkers
por: Varkalaite, Greta, et al.
Publicado: (2022)

Expression and predictive value of miR-489 and miR-21 in melanoma metastasis
por: Mo, Hao, et al.
Publicado: (2019)

Association of miR-146 rs2910164, miR-196a rs11614913, miR-221 rs113054794 and miR-224 rs188519172 polymorphisms with anti-TNF treatment response in a Greek population with Crohn’s disease
por: Papaconstantinou, Ioannis, et al.
Publicado: (2017)

Exosomal miR-182 regulates the effect of RECK on gallbladder cancer
por: Zheng, Hong, et al.
Publicado: (2020)

Correlation of plasma miR-21 and miR-93 with radiotherapy and chemotherapy efficacy and prognosis in patients with esophageal squamous cell carcinoma
por: Wang, Wen-Tao, et al.
Publicado: (2019)

miR-375 is upregulated in acquired paclitaxel resistance in cervical cancer
por: Shen, Y, et al.
Publicado: (2013)

Demethylation of miR-34a upregulates expression of membrane palmitoylated proteins and promotes the apoptosis of liver cancer cells
por: Li, Fu-Yong, et al.
Publicado: (2021)

MiR-19a-3p regulates the Forkhead box F2-mediated Wnt/β-catenin signaling pathway and affects the biological functions of colorectal cancer cells
por: Yu, Fu-Bing, et al.
Publicado: (2020)

Clinical significance of serum miR-129-5p in patients with diabetes mellitus presenting macrovascular complications
por: He, Xiao-Yun, et al.
Publicado: (2021)

Silencing of circ_002136 sensitizes gastric cancer to paclitaxel by targeting the miR-16-5p/HMGA1 axis
por: Kuang, Zhijian, et al.
Publicado: (2023)

Comparison of genomic and transcriptional microbiome analysis in gastric cancer patients and healthy individuals
por: Nikitina, Darja, et al.
Publicado: (2023)

Epigenetic silencing of miR-200b is associated with cisplatin resistance in bladder cancer
por: Shindo, Tetsuya, et al.
Publicado: (2018)

Targeted Silencing of S100A8 Gene by miR-24 to Increase Chemotherapy Sensitivity of Endometrial Carcinoma Cells to Paclitaxel
por: Lang, Bin, et al.
Publicado: (2016)

LncRNA C9orf139 can regulate the growth of pancreatic cancer by mediating the miR-663a/Sox12 axis
por: Ge, Jin-Nian, et al.
Publicado: (2020)

MiR-26a Enhances the Sensitivity of Gastric Cancer Cells to Cisplatin by Targeting NRAS and E2F2
por: Wen, Lan, et al.
Publicado: (2015)

Cardioprotective effects of miR-34a silencing in a rat model of doxorubicin toxicity
por: Piegari, Elena, et al.
Publicado: (2020)

Silencing of KCNK15-AS1 inhibits lung cancer cell proliferation via upregulation of miR-202 and miR-370
por: Peng, Jun, et al.
Publicado: (2019)

An unbiased silencing screen in muscle cells identifies miR-320a, miR-150, miR-196b, and miR-34c as regulators of skeletal muscle mitochondrial metabolism
por: Dahlmans, Dennis, et al.
Publicado: (2017)

Quantitative assessment of miR34a as an independent prognostic marker in breast cancer
por: Agarwal, Seema, et al.
Publicado: (2015)

Circ_0010235 confers cisplatin resistance in lung cancer by upregulating E2F7 through absorbing miR‐379‐5p
por: Wang, Lifei, et al.
Publicado: (2023)

MiR-522-3p Targets Transcription Factor 4 to Overcome Cisplatin Resistance of Gastric Cells
por: Ma, Guofeng, et al.
Publicado: (2022)

Predictive Value of MiR-219-1, MiR-938, MiR-34b/c, and MiR-218 Polymorphisms for Gastric Cancer Susceptibility and Prognosis
por: Wu, Yanhua, et al.
Publicado: (2017)

LincHOTAIR epigenetically silences miR34a by binding to PRC2 to promote the epithelial-to-mesenchymal transition in human gastric cancer
por: Liu, Y-w, et al.
Publicado: (2015)

Methylation of miR-34a, miR-34b/c, miR-124-1 and miR-203 in Ph-negative myeloproliferative neoplasms
por: Chim, Chor Sang, et al.
Publicado: (2011)

Upregulation of miR-138 Increases Sensitivity to Cisplatin in Hepatocellular Carcinoma by Regulating EZH2
por: Zeng, Taohui, et al.
Publicado: (2021)

Quantitative Proteomic Analysis of Gene Regulation by miR-34a and miR-34c
por: Ebner, Olivia A., et al.
Publicado: (2014)

miR-125b Upregulates miR-34a and Sequentially Activates Stress Adaption and Cell Death Mechanisms in Multiple Myeloma
por: Misso, Gabriella, et al.
Publicado: (2019)

Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy
por: Li, Heng, et al.
Publicado: (2014)

MiR-34c downregulation leads to SOX4 overexpression and cisplatin resistance in nasopharyngeal carcinoma
por: Bissey, Pierre-Antoine, et al.
Publicado: (2020)

miR-34c Targets MET to Improve the Anti-Tumor Effect of Cisplatin on Ovarian Cancer
por: Yang, Shiying, et al.
Publicado: (2020)

Microbiome changes in the gastric mucosa and gastric juice in different histological stages of Helicobacter pylori-negative gastric cancers
por: Sun, Qing-Hua, et al.
Publicado: (2022)

Circular RNA AKT3 upregulates PIK3R1 to enhance cisplatin resistance in gastric cancer via miR-198 suppression
por: Huang, Xiaoxu, et al.
Publicado: (2019)

Posttranscriptional deregulation of Src due to aberrant miR34a and miR203 contributes to gastric cancer development
por: Hao, Qiang, et al.
Publicado: (2013)

Serum interleukin-34 level can be an indicator of liver fibrosis in patients with chronic hepatitis B virus infection
por: Wang, Yin-Qiu, et al.
Publicado: (2018)

MALAT1 silencing suppresses prostate cancer progression by upregulating miR-1 and downregulating KRAS
por: Chang, Junkai, et al.
Publicado: (2018)

Silencing of Long Non-coding RNA MIAT Sensitizes Lung Cancer Cells to Gefitinib by Epigenetically Regulating miR-34a
por: Fu, Yunfeng, et al.
Publicado: (2018)

Silencing of miR-34a Attenuates Cardiac Dysfunction in a Setting of Moderate, but Not Severe, Hypertrophic Cardiomyopathy
por: Bernardo, Bianca C., et al.
Publicado: (2014)

MiR-34a overexpression enhances the inhibitory effect of doxorubicin on HepG2 cells
por: Zheng, Shun-Zhen, et al.
Publicado: (2019)

Endothelial and systemic upregulation of miR-34a-5p fine-tunes senescence in progeria
por: Manakanatas, Christina, et al.
Publicado: (2022)

Erratum to: Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy
por: Li, Heng, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_5q8egpocldt7d82qq73kbpjl4j